1. Home
  2. AMKR vs RGEN Comparison

AMKR vs RGEN Comparison

Compare AMKR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amkor Technology Inc.

AMKR

Amkor Technology Inc.

N/A

Current Price

$53.03

Market Cap

11.9B

Sector

Technology

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$179.65

Market Cap

10.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMKR
RGEN
Founded
1968
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.9B
10.0B
IPO Year
1997
1995

Fundamental Metrics

Financial Performance
Metric
AMKR
RGEN
Price
$53.03
$179.65
Analyst Decision
Buy
Buy
Analyst Count
11
22
Target Price
$76.40
★ $189.70
AVG Volume (30 Days)
★ 3.2M
880.1K
Earning Date
10-26-2026
10-27-2026
Dividend Yield
★ 0.64%
N/A
EPS Growth
4.90
★ 286.96
EPS
★ 0.33
0.24
Revenue
★ $4,052,650,000.00
$141,236,000.00
Revenue This Year
$14.27
$12.04
Revenue Next Year
$12.72
$17.80
P/E Ratio
★ $165.39
$805.46
Revenue Growth
N/A
★ 35.10
52 Week Low
$28.32
$100.99
52 Week High
$96.68
$198.87

Technical Indicators

Market Signals
Indicator
AMKR
RGEN
Relative Strength Index (RSI) 50.72 63.35
Support Level $45.69 $159.22
Resistance Level $52.22 N/A
Average True Range (ATR) 2.01 6.58
MACD 0.57 0.98
Stochastic Oscillator 69.54 75.63

Price Performance

Historical Comparison
AMKR
RGEN

About AMKR Amkor Technology Inc.

Amkor Technology Inc is a OSAT (outsourced semiconductor assembly and test) service provider. It has pioneered the outsourcing of integrated circuit (IC) packaging and test services and is a strategic manufacturing partner for the semiconductor companies, foundries, and electronics original equipment manufacturers (OEMs). The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: